GREAT POINT PARTNERS LLC (Ortav Yehudai, Mr. David Kroin, Dr. Jeffrey R. Jay)

13F Portfolio Filings

Latest 13F report
Q2 2024 - Aug 14, 2024
Value $
$522M
Notable people
Ortav Yehudai, Mr. David Kroin, Dr. Jeffrey R. Jay
Signature - Title
Dr. Jeffrey R. Jay, M.D. - Senior Managing Member
Location
165 Mason Street, 3 Rd Floor, Greenwich, CT
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 33 $522M +$170M -$250M -$79.9M URGN, NGNE, ABVX, MRUS, PLRX 13F-HR 8/14/2024, 04:38 PM
Q1 2024 35 $642M +$222M -$294M -$71.6M NGNE, ALPN, URGN, ABVX, EOLS 13F-HR 5/15/2024, 04:24 PM
Q4 2023 34 $587M +$114M -$189M -$74.9M ALPN, CYTK, URGN, PLRX, RARE 13F-HR 2/14/2024, 04:07 PM
Q3 2023 39 $532M +$165M -$92.4M +$72.8M URGN, ALPN, PLRX, PCVX, RARE 13F-HR 11/14/2023, 04:16 PM
Q2 2023 36 $499M +$135M -$147M -$11.9M ALPN, RARE, PCVX, PLRX, RAPT 13F-HR 8/14/2023, 04:17 PM
Q1 2023 42 $506M +$181M -$150M +$30.4M PLRX, XENE, ALPN, RARE, RAPT 13F-HR 5/15/2023, 04:09 PM
Q4 2022 40 $484M +$219M -$127M +$91.4M PCVX, XENE, RAPT, ALPN, PLRX 13F-HR 2/14/2023, 04:02 PM
Q3 2022 40 $406M +$146M -$166M -$20.8M XENE, JAZZ, PNT, ALPN, TVTX 13F-HR 11/14/2022, 04:24 PM
Q2 2022 33 $377M +$128M -$122M +$5.9M XENE, JAZZ, CYTK, TVTX, PCVX 13F-HR 8/15/2022, 04:25 PM
Q1 2022 29 $413M +$137M -$159M -$21.5M EXEL, XENE, TVTX, BCYC, JAZZ 13F-HR 5/16/2022, 04:24 PM
Q4 2021 35 $447M +$171M -$151M +$20M ARNA, EXEL, XENE, TVTX, ANAB 13F-HR 2/14/2022, 11:22 AM
Q3 2021 35 $423M +$155M -$173M -$17.9M EXEL, ARNA, KDMN, BCAB, RCKT 13F-HR 11/15/2021, 04:36 PM
Q2 2021 28 $447M +$140M -$146M -$6.87M MGNX, RCKT, ARNA, UTHR, PODD 13F-HR 8/16/2021, 04:33 PM
Q1 2021 28 $484M +$165M -$241M -$75.9M MGNX, RCKT, IOVA, SAGE, XENT 13F-HR 5/17/2021, 04:05 PM
Q4 2020 31 $607M +$172M -$884M -$711M GWPH, IOVA, SAGE, ACAD, RCKT 13F-HR 2/16/2021, 04:17 PM
Q3 2020 33 $1.11B +$174M -$336M -$162M IOVA, SAGE, ACAD, ARNA, ZYME 13F-HR 11/16/2020, 04:41 PM
Q2 2020 35 $1.24B +$476M -$244M +$232M CNST, IOVA, ZYME, ACAD, SAGE 13F-HR 8/14/2020, 04:55 PM
Q1 2020 32 $886M +$248M -$330M -$82.1M ACAD, ZYME, PTCT, IOVA, CNST 13F-HR 5/15/2020, 04:04 PM
Q4 2019 34 $1.04B +$386M -$541M -$156M IOVA, ZYME, PTCT, NXTC, TGTX 13F-HR 2/14/2020, 04:17 PM
Q3 2019 34 $945M +$340M -$75.4M +$265M IOVA, ZGNX, ACAD, BOLD, PTCT 13F-HR 11/15/2019, 02:01 PM
Q2 2019 25 $824M +$236M -$356M -$120M IOVA, PTCT, ZGNX, BOLD, KURA 13F-HR 8/14/2019, 04:05 PM
Q1 2019 31 $903M +$181M -$176M +$5.17M PTCT, ZGNX, GBT, BOLD, ACAD 13F-HR 5/14/2019, 04:05 PM
Q4 2018 34 $720M +$350M -$124M +$227M BCRX, IOVA, GBT, XLRN, ACAD 13F-HR 2/14/2019, 09:01 PM
Q3 2018 29 $637M +$180M -$208M -$27.7M BCRX, XLRN, ZFGN, IOVA, UTHR 13F-HR 11/14/2018, 04:00 PM
Q2 2018 31 $633M +$206M -$234M -$27.5M PTCT, KURA, IOVA, BCRX, ONCE 13F-HR 8/14/2018, 04:00 PM
Q1 2018 30 $640M +$213M -$183M +$29.9M IOVA, ARNA, KURA, PTCT, ZGNX 13F-HR 5/14/2018, 04:00 PM
Q4 2017 37 $574M +$222M -$116M +$107M ZGNX, ARNA, KURA, SAGE, GBT 13F-HR 2/14/2018, 04:10 PM
Q3 2017 31 $405M +$77.4M -$290M -$212M ZGNX, ARNA, CNCE, NBIX, FOMX 13F-HR 11/14/2017, 04:02 PM
Q2 2017 32 $520M +$154M -$106M +$47.1M ARNA, ADMS, VNDA, ZGNX, PTCT 13F-HR 8/14/2017, 04:12 PM
Q1 2017 32 $457M +$158M -$176M -$18.1M ADMS, CNCE, SGYPQ, VNDA, RIGL 13F-HR 5/15/2017, 04:00 PM
Q4 2016 31 $454M +$129M -$45.9M +$83.2M ADMS, FOMX, VNDA, SGYPQ, ZGNX 13F-HR 2/14/2017, 04:06 PM
Q3 2016 30 $383M +$108M -$133M -$25.2M VNDA, ADMS, SGYPQ, ZGNX, FOMX 13F-HR 11/14/2016, 05:31 PM
Q2 2016 37 $341M +$127M -$66.9M +$60.2M ADMS, VNDA, SGYPQ, EXEL, DERM 13F-HR 8/15/2016, 04:08 PM
Q1 2016 30 $262M +$95.3M -$2.81M +$92.5M ADMS, FPRX, VNDA, ZGNX, TTPH 13F-HR 5/16/2016, 03:02 PM
Q4 2015 21 $228M +$37M -$78.8M -$41.8M ADMS, FPRX, ZGNX, VNDA, TTPH 13F-HR 2/16/2016, 01:21 PM
Q3 2015 32 $232M +$89.2M -$29.8M +$59.4M VNDA, FPRX, CNXR, ADMS, ZGNX 13F-HR 11/16/2015, 10:58 AM
Q2 2015 31 $253M +$103M -$82.1M +$21.2M CNXR, ADMS, VNDA, FPRX, SGYPQ 13F-HR 8/14/2015, 01:11 PM
Q1 2015 30 $221M +$76.1M -$85.6M -$9.48M CNXR, HPTX, VNDA, OFIX, ADMS 13F-HR 5/15/2015, 11:49 AM
Q4 2014 27 $207M +$85.5M -$111M -$25M CNXR, HPTX, ALIM, OCRX, DSCI 13F-HR 2/17/2015, 09:19 AM
Q3 2014 34 $222M +$82.1M -$65.7M +$16.4M HPTX, NBIX, INFI, ALIM, OPHT 13F-HR 11/14/2014, 10:26 AM
Q2 2014 36 $219M +$92M -$42M +$50M NBIX, HPTX, DSCI, THOR, INFI 13F-HR 8/14/2014, 04:17 PM
Q1 2014 33 $180M +$82.6M -$54.4M +$28.2M FURX, HPTX, PTIE, ALIM, DSCI 13F-HR 5/15/2014, 04:30 PM
Q4 2013 26 $136M $0 $0 HPTX, PTIE, FURX, SSH, AMBI 13F-HR 2/14/2014, 06:17 AM